Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (121-130 of 237) with videos related to

Pageof 24
Sort By:
Clinical Pharmacology and Therapeutics|September 2, 2011
Pharmacogenetics: call to actionM V Relling, H J Guchelaar, D M Roden, et al.
Genesis (New York, N.Y. : 2000)|May 8, 2013
Proliferation of embryonic cardiomyocytes in zebrafish requires the sodium channel scn5LabJ S Bennett, D M Stroud, J R Becker, et al.
The New England Journal of Medicine|February 22, 1990
PropafenoneC Funck-Brentano, H K Kroemer, J T Lee, et al.
Circulation|November 1, 1989
Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillationD M Roden, J T Lee, R L Woosley, et al.
Angiology|February 1, 1987
Pharmacologic evaluation of standard and controlled-release disopyramideL A Siddoway, J T Barbey, D M Roden, et al.
Journal of Pharmaceutical Sciences|February 1, 1990
Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detectionJ Turgeon, H K Kroemer, C Prakash, et al.
Clinical Pharmacology and Therapeutics|August 23, 2012
Strategies for personalized medicine-based research and implementation in the clinical workflowW Lieb, H Völzke, J M Pulley, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmiasJ Turgeon, H N Pavlou, W Wong, et al.
Clinical Pharmacokinetics|January 1, 1984
Potential applications of free drug level monitoring in cardiovascular therapyR L Woosley, L A Siddoway, K Thompson, et al.
Human Mutation|March 29, 2000
Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: evidence for variable hearing phenotype associated with R518XJ Wei, F A Fish, R J Myerburg, et al.
Pageof 24

Showing results (121-130 of 237) with videos related to

Sort By:
Pageof 24
Clinical Pharmacology and Therapeutics|September 2, 2011
Pharmacogenetics: call to actionM V Relling, H J Guchelaar, D M Roden, et al.
Genesis (New York, N.Y. : 2000)|May 8, 2013
Proliferation of embryonic cardiomyocytes in zebrafish requires the sodium channel scn5LabJ S Bennett, D M Stroud, J R Becker, et al.
The New England Journal of Medicine|February 22, 1990
PropafenoneC Funck-Brentano, H K Kroemer, J T Lee, et al.
Circulation|November 1, 1989
Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillationD M Roden, J T Lee, R L Woosley, et al.
Angiology|February 1, 1987
Pharmacologic evaluation of standard and controlled-release disopyramideL A Siddoway, J T Barbey, D M Roden, et al.
Journal of Pharmaceutical Sciences|February 1, 1990
Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detectionJ Turgeon, H K Kroemer, C Prakash, et al.
Clinical Pharmacology and Therapeutics|August 23, 2012
Strategies for personalized medicine-based research and implementation in the clinical workflowW Lieb, H Völzke, J M Pulley, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmiasJ Turgeon, H N Pavlou, W Wong, et al.
Clinical Pharmacokinetics|January 1, 1984
Potential applications of free drug level monitoring in cardiovascular therapyR L Woosley, L A Siddoway, K Thompson, et al.
Human Mutation|March 29, 2000
Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: evidence for variable hearing phenotype associated with R518XJ Wei, F A Fish, R J Myerburg, et al.
Pageof 24